Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA and RNA synthesis machinery refers collectively to the cellular systems responsible for replicating genetic material (DNA replication), transcribing DNA into RNA (transcription), and translating RNA into proteins (translation). Key components include DNA polymerases, RNA polymerases, ribosomes, and various accessory factors (e.g., primase, transcription factors, splicing factors). While these processes are vital for all cellular life, their individual components can serve as drug targets, especially in pathogens (e.g., bacterial RNA polymerase, viral reverse transcriptase) or rapidly proliferating cells (e.g., cancer). However, the broad term "DNA and RNA synthesis machinery" does not designate a specific molecular target, but rather a functional category encompassing multiple, distinct macromolecules essential for gene expression and cell viability.
Inhibition of polymerase active sites (blocking DNA or RNA synthesis); Blocking ribosomal function (antibiotics binding to rRNA); Chain termination (nucleoside analogs)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA and RNA synthesis machinery.